Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery

European Journal of Endocrinology

Volumn 165, Issue 5, 2011, Pages 729-737

  Khalil, Roula Bou ^a   Baudry, Camille ^a,b,c   Guignat, Laurence ^a   Carrasco, Carmen ^a,b   Guibourdenche, Jean ^a,c   Gaillard, Stéphane ^d   Bertagna, Xavier ^a,b,c   Bertherat, Jérôme ^a,b,c  

^a Hôpital Cochin ^*  (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; HYDROCORTISONE; LYPRESSIN;

ACTH SECRETING ADENOMA; ADOLESCENT; ADRENAL CORTEX HYPERFUNCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; ENDOCRINE FUNCTION TEST; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE SALIVA LEVEL; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPOCORTISOLISM; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; SALIVA LEVEL; TRANSSPHENOIDAL SURGERY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; PITUITARY GLAND; RECURRENCE; RETROSPECTIVE STUDIES; SALIVARY PROTEINS AND PEPTIDES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054800129     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0424     Document Type: Article

References (45)

1. Dekkers OM, Biermasz NR, Pereira AM, Roelfsema F, van AkenMO, Voormolen JH & Romijn JA. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma. Journal of Clinical Endocrinology and Metabolism 2007 92 976-981. (doi:10.1210/jc. 2006-2112)
2. Newell-Price J, Bertagna X, Grossman AB & Nieman LK. Cushing's syndrome. Lancet 2006 367 1605-1617. (doi:10.1016/S0140-6736(06)68699-6)
3. Etxabe J & Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology 1994 40 479-484. (doi:10.1111/j.1365-2265.1994.tb02486.x)
4. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt- Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K & Weeke J. Incidence and late prognosis of Cushing's syndrome: a population-based study. Journal of Clinical Endocrinology and Metabolism 2001 86 117-123. (doi:10.1210/jc. 86.1.117)
5. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M & Lombardi G. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Journal of Clinical Endocrinology and Metabolism 1999 84 2664-2672. (doi:10.1210/jc.84.8. 2664)
6. Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, Pereira AM & Romijn JA. Subtle cognitive impairments in patients with long-term cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2010 95 2699-2714. (doi:10.1210/jc.2009-2032)
7. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A & Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602. (doi:10.1210/jc.2003-030871)
8. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA & Boscaro M. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2008 93 2454-2462. (doi:10.1210/jc.2007-2734)
9. Atkinson AB, Kennedy A,Wiggam MI, McCance DR & Sheridan B. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clinical Endocrinology 2005 63 549-559. (doi:10.1111/j.1365-2265.2005.02380.x)
10. Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L & Laws ER Jr. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. Journal of Clinical Endocrinology and Metabolism 2008 93 358-362. (doi:10.1210/ jc.2007-2013)
11. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J & Scanlon MF. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clinical Endocrinology 2002 56 541-551. (doi:10. 1046/j.1365-2265.2002.01511.x)
12. Yap LB, Turner HE, Adams CB & Wass JA. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clinical Endocrinology 2002 56 25-31. (doi:10.1046/j.0300- 0664.2001.01444.x)
13. Chee GH, Mathias DB, James RA & Kendall-Taylor P. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clinical Endocrinology 2001 54 617-626. (doi:10. 1046/j.1365-2265.2001.01261.x)
14. Swearingen B, Biller BM, Barker FG II, Katznelson L, Grinspoon S, Klibanski A & Zervas NT. Long-term mortality after transsphenoidal surgery for Cushing disease. Annals of Internal Medicine 1999 130 821-824. (Pubitemid 29231150)
15. Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL & Cutler GB Jr. The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1987 65 906-913. (doi:10.1210/jcem-65-5-906)
16. Bochicchio D, Losa M & Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. Journal of Clinical Endocrinology and Metabolism 1995 80 3114-3120. (doi:10.1210/jc.80.11. 3114)
17. Pieters GF, Hermus AR, Meijer E, Smals AG & Kloppenborg PW. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism 1989 69 1122-1126. (doi:10.1210/jcem-69-6-1122)
18. Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Vila-Porcile E, Olivier L, Racadot J, Derome P, Laudat MH, Girard F, Bricaire H & Luton JP. Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. Journal of Clinical Endocrinology and Metabolism 1988 66 1056-1064. (doi:10.1210/jcem-66-5-1056)
19. Mampalam TJ, Tyrrell JB & Wilson CB. Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Annals of Internal Medicine 1988 109 487-493.
20. Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, Roelfsema F & Romijn JA. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2003 88 5858-5864. (doi:10. 1210/jc.2003-030751)
21. Bigos ST, Somma M, Rasio E, Eastman RC, Lanthier A, Johnston HH & Hardy J. Cushing's disease: management by transsphenoidal pituitary microsurgery. Journal of Clinical Endocrinology and Metabolism 1980 50 348-354. (doi:10.1210/ jcem-50-2-348)
22. Salassa RM, Laws ER Jr, Carpenter PC & Northcutt RC. Transsphenoidal removal of pituitary microadenoma in Cushing's disease. Mayo Clinic Proceedings 1978 53 24-28.
23. Arnott RD, Pestell RG, McKelvie PA, Henderson JK, McNeill PM & Alford FP. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome. Acta Endocrinologica 1990 123 423-430. (Pubitemid 20377193)
24. Chen JC, Amar AP, Choi S, Singer P, Couldwell WT & Weiss MH. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. Journal of Neurosurgery 2003 98 967-973. (doi:10.3171/jns.2003.98.5. 0967)
25. Ram Z, Nieman LK, Cutler GB Jr, Chrousos GP, Doppman JL & Oldfield EH. Early repeat surgery for persistent Cushing's disease. Journal of Neurosurgery 1994 80 37-45. (doi:10.3171/jns.1994. 80.1.0037)
26. Invitti C, Pecori Giraldi F, de Martin M & Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Journal of Clinical Endocrinology and Metabolism 1999 84 440-448. (doi:10.1210/jc.84.2.440)
27. Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A & Wilson CB. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism 2004 89 6348-6357. (doi:10.1210/jc.2003-032180)
28. Romanholi DJ, Machado MC, Pereira CC, Danilovic DS, Pereira MA, Cescato VA, Cunha Neto MB, Musolino NR, de Mendonca BB & Salgado LR. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease. Clinical Endocrinology 2008 69 117-122. (doi:10.1111/j.1365-2265.2007.03168.x)
29. Castinetti F, Martinie M, Morange I, Dufour H, Sturm N, Passagia JG, Conte-Devolx B, Chabre O & Brue T. A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2009 94 1897-1903. (doi:10. 1210/jc.2008-2234)
30. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, SavageMO, Afshar F & Besser GM. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clinical Endocrinology 1993 38 73-78. (doi:10.1111/j.1365-2265.1993.tb00975.x)
31. Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D,Wang C, Swerdloff RS & Kelly DF. Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2006 91 7-13. (doi:10.1210/jc.2005-1204)
32. Estrada J, Garcia-Uria J, Lamas C, Alfaro J, Lucas T, Diez S, Salto L & Barcelo B. The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2001 86 5695-5699. (doi:10.1210/jc.86.12.5695)
33. Rollin GA, Ferreira NP, Junges M, Gross JL & Czepielewski MA. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2004 89 1131-1139. (doi:10. 1210/jc.2003-031170)
34. Losa M, Bianchi R, Barzaghi R, GiovanelliM& Mortini P. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2009 94 3322-3328. (doi:10.1210/jc.2009-0844)
35. Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK & Muller OA. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism 1987 64 1150-1159. (doi:10. 1210/jcem-64-6-1150)
36. Colombo P, Dall'Asta C, Barbetta L, Re T, Passini E, Faglia G & Ambrosi B. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease. European Journal of Endocrinology 2000 143 227-234. (doi:10.1530/eje.0. 1430227)
37. Dall'asta C, Barbetta L, Bonavina L, Beck-Peccoz P & Ambrosi B. Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test. Pituitary 2004 7 183-188. (doi:10.1007/s11102-005-0425-9)
38. Ambrosi B, Malavazos AE, Passeri E & Dall'Asta C. Desmopressin test may predict the risk of recurrence in Cushing's disease. Clinical Endocrinology 2009 70 811. (doi:10.1111/j.1365-2265.2008. 03406.x)
39. Kidambi S, Raff H & Findling JW. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. European Journal of Endocrinology 2007 157 725-731. (doi:10.1530/EJE-07-0424)
40. Guignat L & Bertherat J. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective. European Journal of Endocrinology 2010 163 9-13. (doi:10.1530/EJE-09-0627)
41. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10. 1210/jc.2008-0125)
42. Carrasco CA, Coste J, Guignat L, Groussin L, Dugue MA, Gaillard S, Bertagna X & Bertherat J. Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease. Journal of Clinical Endocrinology and Metabolism 2008 93 4728-4734. (doi:10.1210/jc. 2008-1171)
43. Yaneva M, Mosnier-Pudar H, Dugue MA, Grabar S, Fulla Y & Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. Journal of Clinical Endocrinology and Metabolism 2004 89 3345-3351. (doi:10. 1210/jc.2003-031790)
44. Assie G, Bahurel H, Coste J, Silvera S, Kujas M, Dugue MA, Karray F, Dousset B, Bertherat J, Legmann P & Bertagna X. Corticotroph tumor progression after adrenalectomy in Cushing's disease: a reappraisal of Nelson's syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 172-179. (doi:10.1210/jc.2006-1328)
45. Valero R, Vallette-Kasic S, Conte-Devolx B, Jaquet P & Brue T. The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease. European Journal of Endocrinology 2004 151 727-733. (doi:10.1530/eje.0.1510727)